Protective effect of remifentanil on blood loss in endoscopic subcutaneous mastectomy: a retrospective study
| Autor: | Kyoichi Nakamura, Michio Shimabukuro, Satoshi Yamaguchi, Yukio Takahashi, Kenji Sato, Osamu Kobayashi |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Remifentanil Rhinoplasty lcsh:RD78.3-87.3 03 medical and health sciences 0302 clinical medicine Anesthesiology Medicine 030223 otorhinolaryngology Subcutaneous Mastectomy Mastectomy medicine.diagnostic_test business.industry lcsh:Medical emergencies. Critical care. Intensive care. First aid Blood loss Endoscopy Retrospective cohort study lcsh:RC86-88.9 General Medicine Surgery Blood pressure lcsh:Anesthesiology 030220 oncology & carcinogenesis business Quadrantectomy medicine.drug |
| Zdroj: | Ain Shams Journal of Anesthesiology, Vol 10, Iss 1, Pp 1-9 (2018) |
| ISSN: | 2090-925X |
| Popis: | Background Remifentanil decreases blood loss during spinal surgery, rhinoplasty, and endoscopic sinus surgery. However, there are no reports regarding its effect on intraoperative blood loss during endoscopic body surface surgery. The present study aimed to investigate the effect of intraoperative remifentanil on blood loss during endoscopic subcutaneous mastectomy. Methods In this single-center, retrospective observational study conducted from August 2005 to June 2010, 443 patients who underwent either endoscopic subcutaneous partial mastectomy or quadrantectomy were included (n = 231 and 212, respectively). Patients were categorized into the remifentanil and non-remifentanil groups (n = 154 and 289, respectively) based on intraoperative use of remifentanil. We compared the amount of blood loss between the remifentanil and non-remifentanil groups. Results Blood loss was significantly smaller in the remifentanil group than in the non-remifentanil group in patients undergoing partial mastectomy (median [25%, 75%], 60 [30, 94] vs. 90 [50, 165] ml, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|